2024-05-08 20:08:02 ET
QuidelOrtho Corporation (QDEL)
Q1 2024 Earnings Conference Call
May 08, 2024 5:00 PM ET
Company Participants
Juliet Cunningham – Vice President-Investor Relations
Brian Blaser – President and Chief Executive Officer
Mike Iskra – Executive Vice President and Chief Commercial Officer
Joe Busky – Chief Financial Officer
Conference Call Participants
Jack Meehan – Nephron Research
Maggie Boeye – William Blair
Andrew Cooper – Raymond James
Conor McNamara – RBC
Patrick Donnelly – Citi
Casey Woodring – JPMorgan
Presentation
Operator
Welcome to the QuidelOrtho First Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. For those of you participating on the conference call, there will be an opportunity for questions at the end of today’s prepared remarks. Please note this conference call is being recorded. A audio replay of the conference call will be available on the company’s website shortly after this call.
I would now like to turn the call over to Juliet Cunningham, Vice President of Investor Relations.
Juliet Cunningham
Thank you. Good evening, everyone, and thanks for joining QuidelOrtho first quarter financial results conference call. With me today are Brian Blaser, our newly appointed President and Chief Executive Officer; Mike Iskra, EVP and Chief Commercial Officer; and Joe Busky, Chief Financial Officer. Rob Bujarski, our EVP and Chief Operating Officer, will also join us for the Q&A session that follows our prepared remarks.
This conference call is being simultaneously webcast on the Investor Relations page of our website. To aiding the discussion, we posted a supplemental presentation on the Investor Relations page that will be referenced throughout the call. This conference call contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not strictly historical, including the company’s expectations, plans, future performance, and prospects, are forward-looking statements that are subject to certain risks, uncertainties, assumptions, and other factors. Actual results may vary materially from those expressed or implied in these forward-looking statements....
Read the full article on Seeking Alpha
For further details see:
QuidelOrtho Corporation (QDEL) Q1 2024 Earnings Call Transcript